This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Amgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Stephen Flores in Automated Syringe Quality Evaluation
Introduction
Stephen Flores is an accomplished inventor based in Sherman Oaks, CA (US). He has made significant contributions to the field of automated syringe quality evaluation. His innovative work focuses on enhancing the quality control processes for syringes used in medical applications.
Latest Patents
Stephen Flores holds a patent for "Methods and systems for automated syringe quality evaluation." This patent describes automatic syringe quality control systems, apparatus, and methods that determine a plunger depth within a syringe that has been pre-filled with medication. The plunger depth is assessed based on digital image data, which allows for precise quality evaluation.
Career Highlights
Stephen is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen involves developing advanced technologies that improve the safety and efficacy of medical devices. With a focus on innovation, he has contributed to the company's mission of delivering transformative therapies.
Collaborations
Stephen has collaborated with talented individuals such as Vikashni Padmakumar and Oscar Rosas Andrade. These collaborations have fostered a creative environment that encourages the development of cutting-edge solutions in the field of medical technology.
Conclusion
Stephen Flores is a notable inventor whose work in automated syringe quality evaluation exemplifies the importance of innovation in healthcare. His contributions not only enhance product quality but also ensure patient safety.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
